# Contact Medicinal Tirzepatide | Tirzepatide Research Digest

> Contact the Medicinal Tirzepatide editorial team. This site is a tirzepatide research digest — not a clinic, not a vendor, not a medical service.

## Editorial contact

Medicinal Tirzepatide is an editorial project. We accept correspondence on the following:

— Corrections to citations or factual claims (include the page URL, the claim in question, and the correcting source with its PMID or DOI).
— Citation errors or broken reference links.
— Questions about the scope or methodology of this digest.

We do not provide medical advice. We are not a clinic. We cannot assist with prescriptions, dosing recommendations, treatment decisions, or product sourcing. For questions about tirzepatide as a medical treatment, consult a licensed healthcare provider.

## Editorial disclaimer

This site publishes editorial summaries of publicly available peer-reviewed research. Content on this site does not constitute medical advice, a clinical recommendation, or an endorsement of any compound for human use. Every quantitative claim is cited to a primary source; citations are indexed at [/references](/references).

Timelines in the research record: the SURPASS and SURMOUNT literature is active and expanding. New trial results, safety surveillance findings, and pharmacokinetic sub-studies are published regularly. This digest reflects the literature as of its most recent update. Check the references index for publication years.

---

A numbered schematic reading of the tirzepatide trial record — SURPASS and SURMOUNT endpoints indexed, mechanism annotated, no clinical position held.